Physicochemical Properties
Molecular Formula | C8H15N3O3 |
Molecular Weight | 201.22 |
Exact Mass | 201.111 |
CAS # | 43056-63-9 |
PubChem CID | 3016406 |
Appearance | Off-white to light yellow solid powder |
Density | 1.281g/cm3 |
Boiling Point | 315.8ºC at 760mmHg |
Melting Point | 115-120ºC |
Flash Point | 144.8ºC |
Index of Refraction | 1.536 |
LogP | -1.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 2 |
Heavy Atom Count | 14 |
Complexity | 218 |
Defined Atom Stereocenter Count | 0 |
SMILES | O=C1OC(CN2CCOCC2)CN1N |
InChi Key | TVHAMVOINIHMEX-UHFFFAOYSA-N |
InChi Code | InChI=1S/C8H15N3O3/c9-11-6-7(14-8(11)12)5-10-1-3-13-4-2-10/h7H,1-6,9H2 |
Chemical Name | 3-amino-5-(morpholin-4-ylmethyl)-1,3-oxazolidin-2-one |
HS Tariff Code | 2934.99.9001 |
Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
References | [1]. UmapornPimpitak, et al. Development of a monoclonal antibody-based enzyme-linked immunosorbent assay for detection of the furaltadone metabolite, AMOZ, in fortified shrimp samples. Food Chemistry. Volume 116, Issue 3, 1 October 2009, Pages 785-791. |
Additional Infomation | 3-amino-5-morpholinomethyl-2-oxazolidinone is a member of the class of oxazolidinones that is 3-amino-1,3-oxazolidin-2-one substituted by a morpholin-4-ylmethyl group at position 5. It is the metabolite of furaltadone, a broad-spectrum antibacterial drug which was widely used as an additive in livestock and aquaculture feed. It has a role as a xenobiotic metabolite and a marine xenobiotic metabolite. It is an oxazolidinone and a member of morpholines. |
Solubility Data
Solubility (In Vitro) | DMSO : ~100 mg/mL (~496.97 mM) |
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (12.42 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (12.42 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (12.42 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 4.9697 mL | 24.8484 mL | 49.6968 mL | |
5 mM | 0.9939 mL | 4.9697 mL | 9.9394 mL | |
10 mM | 0.4970 mL | 2.4848 mL | 4.9697 mL |